AGL 38.02 Increased By ▲ 0.08 (0.21%)
AIRLINK 197.36 Increased By ▲ 3.45 (1.78%)
BOP 9.54 Increased By ▲ 0.22 (2.36%)
CNERGY 5.91 Increased By ▲ 0.07 (1.2%)
DCL 8.82 Increased By ▲ 0.14 (1.61%)
DFML 35.74 Decreased By ▼ -0.72 (-1.97%)
DGKC 96.86 Increased By ▲ 4.32 (4.67%)
FCCL 35.25 Increased By ▲ 1.28 (3.77%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.17 Increased By ▲ 0.42 (3.29%)
HUBC 127.55 Increased By ▲ 6.94 (5.75%)
HUMNL 13.50 Decreased By ▼ -0.10 (-0.74%)
KEL 5.32 Increased By ▲ 0.10 (1.92%)
KOSM 7.00 Increased By ▲ 0.48 (7.36%)
MLCF 44.70 Increased By ▲ 2.59 (6.15%)
NBP 61.42 Increased By ▲ 1.61 (2.69%)
OGDC 214.67 Increased By ▲ 3.50 (1.66%)
PAEL 38.79 Increased By ▲ 1.21 (3.22%)
PIBTL 8.25 Increased By ▲ 0.18 (2.23%)
PPL 193.08 Increased By ▲ 2.76 (1.45%)
PRL 38.66 Increased By ▲ 0.49 (1.28%)
PTC 25.80 Increased By ▲ 2.35 (10.02%)
SEARL 103.60 Increased By ▲ 5.66 (5.78%)
TELE 8.30 Increased By ▲ 0.08 (0.97%)
TOMCL 35.00 Decreased By ▼ -0.03 (-0.09%)
TPLP 13.30 Decreased By ▼ -0.25 (-1.85%)
TREET 22.16 Decreased By ▼ -0.57 (-2.51%)
TRG 55.59 Increased By ▲ 2.72 (5.14%)
UNITY 32.97 Increased By ▲ 0.01 (0.03%)
WTL 1.60 Increased By ▲ 0.08 (5.26%)
BR100 11,727 Increased By 342.7 (3.01%)
BR30 36,377 Increased By 1165.1 (3.31%)
KSE100 109,513 Increased By 3238.2 (3.05%)
KSE30 34,513 Increased By 1160.1 (3.48%)

MOSCOW: Russia on Tuesday admitted that its homegrown Sputnik V coronavirus vaccine had not yet been approved by the World Health Organization because Russian authorities had not provided enough data.

In August last year, Sputnik V became the world's first approved coronavirus vaccine, when Russian authorities gave it the green light for domestic use ahead of large-scale clinical trials.

"We still haven't provided certain information that needs to be provided for certification because we had a different understanding of what information it had to be and how it should be provided," Kremlin spokesman Dmitry Peskov told reporters.

"We have different standards."

But Peskov said Russia is "gradually, let's say, adapting to these requirements."

While officials sparked concerns over the fast-track process, the jab was since declared safe and more than 90 percent effective in a report published by leading medical journal The Lancet.

But neither the US nor EU medicines watchdogs have so far granted authorisation for Sputnik V, which has been used in Russia and a host of other countries since late last year.

Russia's Sputnik V vaccine shows 96.3% COVID-19 efficacy in Belarus

The WHO last month said it had restarted the certification process that could grant emergency authorisation for Sputnik V after delaying the process for several months but said it still needed "the full dossier on Sputnik".

At home, Russian authorities have faced a vaccine-sceptic population that has seen just 42 percent of Russians fully inoculated.

A Twitter account associated with jailed opposition leader Alexei Navalny on Tuesday blamed the delayed WHO certification process on the Russian authorities and said that it had contributed to vaccine-scepticism at home.

"People are dying and they are sorting through paper," the account tweeted.

The WHO has so far granted emergency authorisations to Covid-19 shots Pfizer-BioNTech, Moderna, AstraZeneca, Johnson&Johnson, Sinopharm, Sinovac and India's Bharat Biotech.

Comments

Comments are closed.